TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $281,000 | +16.1% | 3,905 | +19.2% | 0.02% | +11.8% |
| Q1 2021 | $242,000 | -8.0% | 3,277 | -31.7% | 0.02% | 0.0% |
| Q3 2020 | $263,000 | -35.2% | 4,800 | -21.3% | 0.02% | -39.3% |
| Q2 2020 | $406,000 | -18.1% | 6,100 | -24.7% | 0.03% | -28.2% |
| Q1 2020 | $496,000 | -30.3% | 8,100 | 0.0% | 0.04% | -11.4% |
| Q4 2019 | $712,000 | -73.2% | 8,100 | -56.2% | 0.04% | -37.1% |
| Q2 2015 | $2,660,000 | +6.3% | 18,512 | +4.4% | 0.07% | +12.9% |
| Q1 2015 | $2,502,000 | +314.9% | 17,740 | +312.6% | 0.06% | +287.5% |
| Q2 2014 | $603,000 | 0.0% | 4,300 | -20.8% | 0.02% | +6.7% |
| Q1 2014 | $603,000 | +80.0% | 5,429 | +60.2% | 0.02% | -62.5% |
| Q4 2013 | $335,000 | +34.0% | 3,389 | +2.9% | 0.04% | +471.4% |
| Q3 2013 | $250,000 | -30.7% | 3,295 | -49.0% | 0.01% | -22.2% |
| Q2 2013 | $361,000 | – | 6,464 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |